InnoCare Pharma is a biopharmaceutical company based in Beijing that discovers, develops and commercialises medicines for cancer and autoimmune diseases. Its main marketed product is a small-molecule drug for certain blood cancers, and its pipeline includes treatments being studied for lymphoma, autoimmune conditions and other diseases. The company serves patients and physicians through hospitals and healthcare providers in China, and it also conducts clinical development work aimed at broader markets.
The shares are listed on the Shanghai Stock Exchange in China under the code 688428, and the price on this page is in Chinese yuan (CNY). Our records, which start in 2019, show no dividend payments for it. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Market X-Ray · price-based
Strong price profile
Ranks #276 of 2278 on the Shanghai Stock Exchange · confidence High
What this score is, and is not
It describes how this stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is. That fundamental X-Ray needs financial statements, which we do not have for China yet.
TrendStrong
90/100
Trading above its long-term averages and near its highs.
See the numbers →
Above 200-day average2.5%
From 52-week high-20.4%
MomentumFair
65/100
Typical recent returns for this exchange.
See the numbers →
3-month return-6.2%
6-month return-6.3%
12-month, skipping last month51.5%
Stability (higher is calmer)Fair
54/100
Typical risk for this exchange.
See the numbers →
Volatility, 1 year (lower is calmer)53.8%
Worst drawdown, 1 year (smaller is calmer)-35.0%
LiquidityStrong
76/100
Trades actively.
See the numbers →
Avg daily value traded361.60M CNY
Zero-volume days0.0%
IncomeNone
–/100
Pays no dividend.
See the numbers →
Years with dividends0
Price-based X-Ray. The fundamental X-Ray (financial health, valuation, growth, fair value) is available for US stocks today. It will follow for China when fundamentals data for this market is added. All China stocks.
52-wk range 19.36 – 35.00Daily closes, split-adjusted
Signals
50-day average28.99
200-day average25.96
Golden/death cross (60d)None
New 52-week highNo
Bullish RSI divergenceNo
Average daily range (ATR)1.74
Technical summary
Daily
Bearish
3 bullish · 4 neutral · 9 bearish
Weekly
Bullish
7 bullish · 1 neutral · 4 bearish
Monthly
Strongly bullish
7 bullish · 1 neutral · 0 bearish
Moving averages (daily)
SMA 10
26.30
Bullish
EMA 10
26.69
Bearish
SMA 20
27.94
Bearish
EMA 20
27.38
Bearish
SMA 50
28.99
Bearish
EMA 50
28.05
Bearish
SMA 100
27.49
Bearish
EMA 100
27.70
Bearish
SMA 200
25.96
Bullish
EMA 200
26.58
Bullish
Oscillators (daily)
RSI (14)
45.16
Neutral
MACD (12, 26)
-0.81
Bearish
Momentum (12)
-8.62
Bearish
Stochastic %K (14)
30.52
Neutral
Williams %R (14)
-69.48
Neutral
CCI (20)
-70.66
Neutral
Pivot points (classic, last session)
S3
24.01
S2
24.59
S1
25.60
Pivot
26.18
R1
27.19
R2
27.77
R3
28.78
Signals describe what the chart is doing, not what to do. Moving averages: price above the average is bullish. Oscillators use the usual thresholds (RSI 30/70, Stochastic 20/80, CCI ±100, Williams %R −80/−20; MACD and momentum above zero are bullish). Weekly and monthly views use closing prices only.
Prices are end-of-day closes in CNY. Educational only, not financial advice.
